Bottom line
MDEV vs RSPH: the short answer
MDEV (First Trust Indxx Medical Devices ETF) and RSPH (Invesco S&P 500 Equal Weight Health Care ETF) are quite different portfolios: only about 19% of their top holdings (by weight) are shared.
RSPH is cheaper at 0.4% vs 0.7% — a difference of $30 a year per $10,000 invested.
Over one year, RSPH returned +9.3% vs +2.0% for MDEV.
Updated Nov 19, 2026
MDEV vs RSPH side by side
| MDEV | RSPH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | First Trust | Invesco |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.7% | 0.4% |
| Annual cost per $10k | $70 | $40 |
| 10-yr cost on $10k (prospectus) | — | $505 |
| Max front load | None | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +2.0% | +9.3% |
| 5-yr return (annualized) | — | +4.7% |
| 10-yr return (annualized) | — | +8.2% |
| Best quarter | +15.5% | +17.5% |
| Worst quarter | −19.1% | −14.3% |
| Net assets (fund) | $1.9M | $766.9M |
| Number of holdings | 51 | 63 |
| Portfolio turnover | 2% | 24% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | MDEV | RSPH | Difference |
|---|---|---|---|
| 2025 | +2.0% | +9.3% | −7.3% |
| 2024 | +2.2% | −0.8% | +3.0% |
| 2023 | +7.2% | +3.9% | +3.2% |
| 2022 | −28.4% | −9.2% | −19.1% |
Source: Fund prospectus bar charts
Holdings overlap
5 of MDEV's top 25 holdings also appear in RSPH's top 25.
| Holding | MDEV | RSPH |
|---|---|---|
| Baxter International Inc | 2.55% | 1.99% |
| Revvity Inc | 2.54% | 1.72% |
| Dexcom Inc | 2.16% | 1.73% |
| Thermo Fisher Scientific Inc | 2.06% | 1.84% |
| Becton Dickinson & Company | 2.01% | 1.73% |
Source: SEC Form N-PORT
MDEV top 10
- West Pharmaceutical Services Inc — 2.86%
- Demant A/s — 2.70%
- Livanova Plc — 2.69%
- Baxter International Inc — 2.55%
- Revvity Inc — 2.54%
- Straumann Holding Ag — 2.53%
- Wuxi Apptec Co Ltd — 2.44%
- Waters Corp — 2.40%
- Edwards Lifesciences Corp — 2.38%
- Agilent Technologies Inc — 2.37%
RSPH top 10
- Bio-Techne Corp. — 2.13%
- IQVIA Holdings Inc. — 2.00%
- Baxter International Inc. — 1.99%
- Regeneron Pharmaceuticals, Inc. — 1.96%
- Mettler-Toledo International Inc. — 1.94%
- Charles River Laboratories International, Inc. — 1.93%
- Veeva Systems Inc. — 1.93%
- DaVita Inc. — 1.87%
- Moderna, Inc. — 1.85%
- Thermo Fisher Scientific Inc. — 1.84%
FAQ
What is the difference between MDEV and RSPH?
Which is cheaper, MDEV or RSPH?
Should I own both MDEV and RSPH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.